Heart Tronics Stock

Heart Tronics Equity

The The Equity of Heart Tronics (HRTT) as of Aug 4, 2026 is 2.96 M USD.

Equity

2.96 MUSD

Last updated:

In 2026, Heart Tronics's equity was 2.96 M USD, a % increase from the - USD equity in the previous year.

Access this data via the Eulerpool API

Heart Tronics Stock analysis

What does Heart Tronics do? Heart Tronics Inc. is a company specializing in the development of medical devices and technologies aimed at monitoring and treating heart diseases. It was founded in 2000 by Dr. A. Martin Gerdes and is headquartered in Irvine, California. The company's business model is based on the development, production, and sale of life-saving medical devices. They offer a wide range of diagnostic and monitoring devices that help doctors diagnose and treat heart diseases. One of their main focuses is the development of devices for monitoring heart rhythm disorders, including factors like blood pressure, pulse rate, and respiratory rate. They also develop devices for the treatment of heart diseases, such as electrophysiological (EP) ablation devices and implantable cardioverter-defibrillators (ICD). Additionally, they have developed telemedicine products for remote patient monitoring, allowing doctors to monitor and analyze patient data in real time. Overall, Heart Tronics has developed a variety of products that have proven effective in the medical community and are focused on saving lives by helping doctors detect diseases and take preventive measures. The company is well positioned for future growth due to advancements in telemedicine and medical devices. They plan to expand their portfolio to develop even more life-saving technologies in the future. In conclusion, Heart Tronics is a company driven by the clear goal of saving lives. They have established themselves as pioneers in the development of medical devices for the treatment of heart diseases and are committed to continuously developing innovative technologies to improve people's lives. Heart Tronics is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Heart Tronics's Equity

Heart Tronics's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Heart Tronics's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Heart Tronics's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Heart Tronics's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Heart Tronics’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Heart Tronics stock

The Equity of Heart Tronics is 2.96 M USD in 2026.

On Eulerpool you can find the complete historical development of The Equity Heart Tronics since 2006 – with annual values, charts, and detailed analysis.

The Equity's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Heart Tronics historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Heart Tronics

All Key Metrics — Heart Tronics